Haemochromatosis.
Identifieur interne : 001D29 ( PubMed/Checkpoint ); précédent : 001D28; suivant : 001D30Haemochromatosis.
Auteurs : Lawrie W. Powell [Australie] ; Rebecca C. Seckington [Australie] ; Yves Deugnier [France]Source :
- Lancet (London, England) [ 1474-547X ] ; 2016.
Descripteurs français
- KwdFr :
- Antigènes d'histocompatibilité de classe I (génétique), Consommation d'alcool (effets indésirables), Dépistage génétique, Dépistage systématique (), Dépistage systématique (normes), Europe (épidémiologie), Exposition environnementale, Facteurs de risque, Facteurs sexuels, Fer (métabolisme), Ferritines (sang), Foie (), Foie (métabolisme), Génotype, Hepcidines (déficit), Humains, Hémochromatose (), Hémochromatose (diagnostic), Hémochromatose (génétique), Hémochromatose (physiopathologie), Incertitude, Maladies du foie (), Maladies du foie (physiopathologie), Maladies du foie (étiologie), Mutation, Phlébotomie, Phénotype, Polymorphisme de nucléotide simple, Population d'origine européenne (génétique), Prise en charge de la maladie, Protéine de l'hémochromatose, Protéines membranaires (génétique), Récepteurs à la transferrine (génétique), Transporteurs de cations (génétique).
- MESH :
- diagnostic : Hémochromatose.
- déficit : Hepcidines.
- effets indésirables : Consommation d'alcool.
- génétique : Antigènes d'histocompatibilité de classe I, Hémochromatose, Population d'origine européenne, Protéines membranaires, Récepteurs à la transferrine, Transporteurs de cations.
- métabolisme : Fer, Foie.
- normes : Dépistage systématique.
- physiopathologie : Hémochromatose, Maladies du foie.
- sang : Ferritines.
- épidémiologie : Europe.
- étiologie : Maladies du foie.
- Dépistage génétique, Dépistage systématique, Exposition environnementale, Facteurs de risque, Facteurs sexuels, Foie, Génotype, Humains, Hémochromatose, Incertitude, Maladies du foie, Mutation, Phlébotomie, Phénotype, Polymorphisme de nucléotide simple, Prise en charge de la maladie, Protéine de l'hémochromatose.
English descriptors
- KwdEn :
- Alcohol Drinking (adverse effects), Cation Transport Proteins (genetics), Disease Management, Environmental Exposure, Europe (epidemiology), European Continental Ancestry Group (genetics), Ferritins (blood), Genetic Testing, Genotype, Hemochromatosis (diagnosis), Hemochromatosis (genetics), Hemochromatosis (physiopathology), Hemochromatosis (therapy), Hemochromatosis Protein, Hepcidins (deficiency), Histocompatibility Antigens Class I (genetics), Humans, Iron (metabolism), Liver (drug effects), Liver (metabolism), Liver Diseases (etiology), Liver Diseases (physiopathology), Liver Diseases (therapy), Mass Screening (methods), Mass Screening (standards), Membrane Proteins (genetics), Mutation, Phenotype, Phlebotomy, Polymorphism, Single Nucleotide, Receptors, Transferrin (genetics), Risk Factors, Sex Factors, Uncertainty.
- MESH :
- chemical , blood : Ferritins.
- chemical , deficiency : Hepcidins.
- chemical , genetics : Cation Transport Proteins, Histocompatibility Antigens Class I, Membrane Proteins, Receptors, Transferrin.
- adverse effects : Alcohol Drinking.
- diagnosis : Hemochromatosis.
- drug effects : Liver.
- epidemiology : Europe.
- etiology : Liver Diseases.
- genetics : European Continental Ancestry Group, Hemochromatosis.
- chemical , metabolism : Iron, Liver.
- methods : Mass Screening.
- physiopathology : Hemochromatosis, Liver Diseases.
- standards : Mass Screening.
- therapy : Hemochromatosis, Liver Diseases.
- Disease Management, Environmental Exposure, Genetic Testing, Genotype, Hemochromatosis Protein, Humans, Mutation, Phenotype, Phlebotomy, Polymorphism, Single Nucleotide, Risk Factors, Sex Factors, Uncertainty.
Abstract
Haemochromatosis is now known to be an iron-storage disease with genetic heterogeneity but with a final common metabolic pathway resulting in inappropriately low production of the hormone hepcidin. This leads to increase in intestinal absorption and deposition of excessive amounts of iron in parenchymal cells which in turn results in eventual tissue damage and organ failure. A clinical enigma has been the variable clinical expression with some patients presenting with hepatic cirrhosis at a young age and others almost asymptomatic for life. Research is unravelling this puzzle by identifying environmental factors-especially alcohol consumption-and associated modifying genes that modulate phenotypic expression. A high index of suspicion is required for early diagnosis but this can lead to presymptomatic therapy and a normal life expectancy. Venesection (phlebotomy) therapy remains the mainstay of therapy, but alternative therapies are the subject of current research.
DOI: 10.1016/S0140-6736(15)01315-X
PubMed: 26975792
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26975792Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Haemochromatosis.</title><author><name sortKey="Powell, Lawrie W" sort="Powell, Lawrie W" uniqKey="Powell L" first="Lawrie W" last="Powell">Lawrie W. Powell</name><affiliation wicri:level="1"><nlm:affiliation>Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane, Australia. Electronic address: lawrie.powell@qimrberghofer.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Seckington, Rebecca C" sort="Seckington, Rebecca C" uniqKey="Seckington R" first="Rebecca C" last="Seckington">Rebecca C. Seckington</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Deugnier, Yves" sort="Deugnier, Yves" uniqKey="Deugnier Y" first="Yves" last="Deugnier">Yves Deugnier</name><affiliation wicri:level="3"><nlm:affiliation>University Hospital and University of Rennes 1, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Hospital and University of Rennes 1, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26975792</idno><idno type="pmid">26975792</idno><idno type="doi">10.1016/S0140-6736(15)01315-X</idno><idno type="wicri:Area/PubMed/Corpus">001A67</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A67</idno><idno type="wicri:Area/PubMed/Curation">001A43</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A43</idno><idno type="wicri:Area/PubMed/Checkpoint">001A43</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A43</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Haemochromatosis.</title><author><name sortKey="Powell, Lawrie W" sort="Powell, Lawrie W" uniqKey="Powell L" first="Lawrie W" last="Powell">Lawrie W. Powell</name><affiliation wicri:level="1"><nlm:affiliation>Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane, Australia. Electronic address: lawrie.powell@qimrberghofer.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Seckington, Rebecca C" sort="Seckington, Rebecca C" uniqKey="Seckington R" first="Rebecca C" last="Seckington">Rebecca C. Seckington</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Deugnier, Yves" sort="Deugnier, Yves" uniqKey="Deugnier Y" first="Yves" last="Deugnier">Yves Deugnier</name><affiliation wicri:level="3"><nlm:affiliation>University Hospital and University of Rennes 1, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>University Hospital and University of Rennes 1, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation></author></analytic><series><title level="j">Lancet (London, England)</title><idno type="eISSN">1474-547X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alcohol Drinking (adverse effects)</term><term>Cation Transport Proteins (genetics)</term><term>Disease Management</term><term>Environmental Exposure</term><term>Europe (epidemiology)</term><term>European Continental Ancestry Group (genetics)</term><term>Ferritins (blood)</term><term>Genetic Testing</term><term>Genotype</term><term>Hemochromatosis (diagnosis)</term><term>Hemochromatosis (genetics)</term><term>Hemochromatosis (physiopathology)</term><term>Hemochromatosis (therapy)</term><term>Hemochromatosis Protein</term><term>Hepcidins (deficiency)</term><term>Histocompatibility Antigens Class I (genetics)</term><term>Humans</term><term>Iron (metabolism)</term><term>Liver (drug effects)</term><term>Liver (metabolism)</term><term>Liver Diseases (etiology)</term><term>Liver Diseases (physiopathology)</term><term>Liver Diseases (therapy)</term><term>Mass Screening (methods)</term><term>Mass Screening (standards)</term><term>Membrane Proteins (genetics)</term><term>Mutation</term><term>Phenotype</term><term>Phlebotomy</term><term>Polymorphism, Single Nucleotide</term><term>Receptors, Transferrin (genetics)</term><term>Risk Factors</term><term>Sex Factors</term><term>Uncertainty</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe I (génétique)</term><term>Consommation d'alcool (effets indésirables)</term><term>Dépistage génétique</term><term>Dépistage systématique ()</term><term>Dépistage systématique (normes)</term><term>Europe (épidémiologie)</term><term>Exposition environnementale</term><term>Facteurs de risque</term><term>Facteurs sexuels</term><term>Fer (métabolisme)</term><term>Ferritines (sang)</term><term>Foie ()</term><term>Foie (métabolisme)</term><term>Génotype</term><term>Hepcidines (déficit)</term><term>Humains</term><term>Hémochromatose ()</term><term>Hémochromatose (diagnostic)</term><term>Hémochromatose (génétique)</term><term>Hémochromatose (physiopathologie)</term><term>Incertitude</term><term>Maladies du foie ()</term><term>Maladies du foie (physiopathologie)</term><term>Maladies du foie (étiologie)</term><term>Mutation</term><term>Phlébotomie</term><term>Phénotype</term><term>Polymorphisme de nucléotide simple</term><term>Population d'origine européenne (génétique)</term><term>Prise en charge de la maladie</term><term>Protéine de l'hémochromatose</term><term>Protéines membranaires (génétique)</term><term>Récepteurs à la transferrine (génétique)</term><term>Transporteurs de cations (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Ferritins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en"><term>Hepcidins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Cation Transport Proteins</term><term>Histocompatibility Antigens Class I</term><term>Membrane Proteins</term><term>Receptors, Transferrin</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Alcohol Drinking</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemochromatosis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hémochromatose</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Liver</term></keywords><keywords scheme="MESH" qualifier="déficit" xml:lang="fr"><term>Hepcidines</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Consommation d'alcool</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Europe</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Liver Diseases</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>European Continental Ancestry Group</term><term>Hemochromatosis</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe I</term><term>Hémochromatose</term><term>Population d'origine européenne</term><term>Protéines membranaires</term><term>Récepteurs à la transferrine</term><term>Transporteurs de cations</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Iron</term><term>Liver</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Fer</term><term>Foie</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Dépistage systématique</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Hémochromatose</term><term>Maladies du foie</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hemochromatosis</term><term>Liver Diseases</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Ferritines</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemochromatosis</term><term>Liver Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies du foie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Management</term><term>Environmental Exposure</term><term>Genetic Testing</term><term>Genotype</term><term>Hemochromatosis Protein</term><term>Humans</term><term>Mutation</term><term>Phenotype</term><term>Phlebotomy</term><term>Polymorphism, Single Nucleotide</term><term>Risk Factors</term><term>Sex Factors</term><term>Uncertainty</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dépistage génétique</term><term>Dépistage systématique</term><term>Exposition environnementale</term><term>Facteurs de risque</term><term>Facteurs sexuels</term><term>Foie</term><term>Génotype</term><term>Humains</term><term>Hémochromatose</term><term>Incertitude</term><term>Maladies du foie</term><term>Mutation</term><term>Phlébotomie</term><term>Phénotype</term><term>Polymorphisme de nucléotide simple</term><term>Prise en charge de la maladie</term><term>Protéine de l'hémochromatose</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Haemochromatosis is now known to be an iron-storage disease with genetic heterogeneity but with a final common metabolic pathway resulting in inappropriately low production of the hormone hepcidin. This leads to increase in intestinal absorption and deposition of excessive amounts of iron in parenchymal cells which in turn results in eventual tissue damage and organ failure. A clinical enigma has been the variable clinical expression with some patients presenting with hepatic cirrhosis at a young age and others almost asymptomatic for life. Research is unravelling this puzzle by identifying environmental factors-especially alcohol consumption-and associated modifying genes that modulate phenotypic expression. A high index of suspicion is required for early diagnosis but this can lead to presymptomatic therapy and a normal life expectancy. Venesection (phlebotomy) therapy remains the mainstay of therapy, but alternative therapies are the subject of current research.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26975792</PMID><DateCreated><Year>2016</Year><Month>08</Month><Day>18</Day></DateCreated><DateCompleted><Year>2016</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>388</Volume><Issue>10045</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Haemochromatosis.</ArticleTitle><Pagination><MedlinePgn>706-16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(15)01315-X</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(15)01315-X</ELocationID><Abstract><AbstractText>Haemochromatosis is now known to be an iron-storage disease with genetic heterogeneity but with a final common metabolic pathway resulting in inappropriately low production of the hormone hepcidin. This leads to increase in intestinal absorption and deposition of excessive amounts of iron in parenchymal cells which in turn results in eventual tissue damage and organ failure. A clinical enigma has been the variable clinical expression with some patients presenting with hepatic cirrhosis at a young age and others almost asymptomatic for life. Research is unravelling this puzzle by identifying environmental factors-especially alcohol consumption-and associated modifying genes that modulate phenotypic expression. A high index of suspicion is required for early diagnosis but this can lead to presymptomatic therapy and a normal life expectancy. Venesection (phlebotomy) therapy remains the mainstay of therapy, but alternative therapies are the subject of current research.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Lawrie W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Centre for the Advancement of Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, The University of Queensland, Brisbane, Australia. Electronic address: lawrie.powell@qimrberghofer.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seckington</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deugnier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University Hospital and University of Rennes 1, Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027682">Cation Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C103673">HFE protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071020">Hemochromatosis Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064451">Hepcidins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011990">Receptors, Transferrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C503640">TFR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409881">metal transporting protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-73-2</RegistryNumber><NameOfSubstance UI="D005293">Ferritins</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000428" MajorTopicYN="N">Alcohol Drinking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027682" MajorTopicYN="N">Cation Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005293" MajorTopicYN="N">Ferritins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="Y">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006432" MajorTopicYN="Y">Hemochromatosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071020" MajorTopicYN="N">Hemochromatosis Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064451" MajorTopicYN="N">Hepcidins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018962" MajorTopicYN="Y">Phlebotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011990" MajorTopicYN="N">Receptors, Transferrin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035501" MajorTopicYN="N">Uncertainty</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26975792</ArticleId><ArticleId IdType="pii">S0140-6736(15)01315-X</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(15)01315-X</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>France</li></country><region><li>Région Bretagne</li></region><settlement><li>Rennes</li></settlement></list><tree><country name="Australie"><noRegion><name sortKey="Powell, Lawrie W" sort="Powell, Lawrie W" uniqKey="Powell L" first="Lawrie W" last="Powell">Lawrie W. Powell</name></noRegion><name sortKey="Seckington, Rebecca C" sort="Seckington, Rebecca C" uniqKey="Seckington R" first="Rebecca C" last="Seckington">Rebecca C. Seckington</name></country><country name="France"><region name="Région Bretagne"><name sortKey="Deugnier, Yves" sort="Deugnier, Yves" uniqKey="Deugnier Y" first="Yves" last="Deugnier">Yves Deugnier</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001D29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26975792
|texte= Haemochromatosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26975792" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |